Drug Transporter (DT) Information

General Information of DT
DT ID DTD0342
Gene Name SLC39A14
Protein Name Zinc transporter ZIP14
Gene ID
23516
UniProt ID
Q15043
TCDB ID
2.A.5.4.5
3D Structure

Modelled DT Structure

Method: multi-sequence alignment based machine learning

Detail: Structure Info

Synonyms HCIN; HMNDYT2; KIAA0062; LIV-1 subfamily of ZIP zinc transporter 4; LZT-Hs4; NET34; SLC39A14; Solute carrier family 39 member 14; ZIP-14; ZIP14; Zinc transporter ZIP14; cig19
DT Family Zinc (Zn(2+))-Iron (Fe(2+)) Permease (ZIP) Family ;
Tissue Specificity Expressed in liver and in brain by largeneurons in the globus pallidus, the insular cortex and the dentatenucleus and to a lower extent in the putamen and the caudatenucleus (at protein level) (PubMed:27231142). Isoform 1 isubiquitously expressed, with increased expression in liver,pancreas, fetal liver, thyroid gland, left and right ventricle,right atrium and fetal heart. Weakly expressed in spleen, thymus,and peripheral blood leukocytes (PubMed:15642354, PubMed:7584044,PubMed:27231142). Isoform 3 is widely expressed but not detectedin brain, heart, skeletal muscle and fetal skin (PubMed:27231142).Expressed in osteoblasts and giant osteoclast-like cells, but notin osteocytes found osteoblastoma and giant cell tumors (atprotein level) (PubMed:29621230).
Function This transporter is broad-scope metal ion transporter with a preference for zinc uptake and also mediates cellular uptake of nontransferrin-bound iron.
Endogenous Substrate(s) Cd2+; Mn2+; Zn2+
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Zinc salts
 Preclinical Drug Info Arthritis FA5Z [1]
References
1 SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice. Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):E1769-E1778.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.